New technology offer: highly selective, orally bioavailable FAP inhibitors
Please see the following link/
Technology offer: New lead compounds for dry eye disease and validated dry eye disease rat model
Please see the following link:
Technology offer: Validated gastrointestinal model of visceral pain for preclinical drug testing
Please see the following link:
Technology offer: New serine protease inhibitors to treat visceral pain for preclinical drug testing
Please see the following link: